These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 1596692)
1. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. Hogaboam CM; Donigi-Gale D; Shoupe TS; Bissonnette EY; Befus AD; Wallace JL Br J Pharmacol; 1992 Jan; 105(1):87-92. PubMed ID: 1596692 [TBL] [Abstract][Full Text] [Related]
2. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro. Lohde C; Bahr T; Labes D; Grupe R Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025 [TBL] [Abstract][Full Text] [Related]
3. The effect of platelet-activating factor on histamine release from guinea pig peritoneal mast cells. Misawa M; Huang SC; Chiu MH J Pharmacobiodyn; 1991 Feb; 14(2):61-5. PubMed ID: 1714503 [TBL] [Abstract][Full Text] [Related]
4. The effect of platelet-activating factor on histamine release from rat peritoneal mast cells. Misawa M; Huang SC Jpn J Pharmacol; 1990 May; 53(1):75-80. PubMed ID: 1693706 [TBL] [Abstract][Full Text] [Related]
5. Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions. Pellon MI; Fernandez-Gallardo S; Gijon MA; Garcia MC; Liu FT; Sanchez Crespo M Immunopharmacology; 1993; 26(1):73-82. PubMed ID: 8407286 [TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor does not release histamine from human dispersed cutaneous mast cells. Thomas G; Church MK Clin Exp Allergy; 1990 Jul; 20(4):377-82. PubMed ID: 1695868 [TBL] [Abstract][Full Text] [Related]
8. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. Mencia-Huerta JM; Lewis RA; Razin E; Austen KF J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819 [TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of esculentoside A on platelet activating factor released from calcimycin induced rat peritoneal macrophages]. Fang J; Zheng QY Yao Xue Xue Bao; 1991; 26(10):721-4. PubMed ID: 1823713 [TBL] [Abstract][Full Text] [Related]
16. Modulation of mast cell activity by a peptide agonist of the thrombin receptor: role of nitric oxide. Strukova SM; Chistov IV; Umarova BA; Dugina TN; Storozhevykh TP; Pinelis VG; Glusa E Biochemistry (Mosc); 1999 Jun; 64(6):658-64. PubMed ID: 10395981 [TBL] [Abstract][Full Text] [Related]
17. PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase. Glaser KB; Lock YW; Chang JY Agents Actions; 1991 Sep; 34(1-2):89-92. PubMed ID: 1665306 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids. Sturk A; Schaap MC; Prins A; ten Cate JW; van den Bosch H Biochim Biophys Acta; 1989 Dec; 993(2-3):148-56. PubMed ID: 2512985 [TBL] [Abstract][Full Text] [Related]
19. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; GarcĂa-Rafanell J; Forn J J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [TBL] [Abstract][Full Text] [Related]
20. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Hwang SB; Li CL; Lam MH; Shen TY Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]